Publicaciones en colaboración con investigadores/as de Hospital del Mar (8)

2022

  1. Comparison of three short-course rifamycinbased regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)

    PLoS ONE, Vol. 17, Núm. 10 October

2020

  1. Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on

    Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492

2017

  1. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

    The Lancet Respiratory Medicine, Vol. 5, Núm. 4, pp. 259-268

2016

  1. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 12, pp. 1007.e1-1007.e5

  2. Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection

    Archivos de Bronconeumologia, Vol. 52, Núm. 9, pp. 477-481

  3. Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 304-308

  4. Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 303.e1-303.e13

  5. Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment

    Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268